CNS Pharmaceuticals CEO John Climaco's 2020 pay jumps 28% to $1.6M
CNS Pharmaceuticals reports 2020 executive compensation
By ExecPay News
Published: June 7, 2021
CNS Pharmaceuticals reported fiscal year 2020 executive compensation information on June 7, 2021.
In 2020, three executives at CNS Pharmaceuticals received on average a compensation package of $902K, a 2% increase compared to previous year.
Average pay of disclosed executives at CNS Pharmaceuticals
John Climaco, Chief Executive Officer, received $1.6M in total, which increased by 28% compared to 2019. 60% of Climaco's compensation, or $938K, was in option awards. Climaco also received $195K in non-equity incentive plan and $440K in salary.
Christopher Downs, Chief Financial Officer, received a compensation package of $791K, which decreased by 31% compared to previous year. 50% of the compensation package, or $396K, was in option awards.
Sandra Silberman, Chief Medical Officer, earned $341K in 2020, a 25% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on June 7, 2021.